HEALTH● LOWJul 15 · Jul 15, 2026, 3:35 PM
Roche/ Biogen kidney drug granted FDA priority review for label expansion
Seeking Alpha Tech
A kidney drug developed by Roche and Biogen has been granted priority review by the FDA for an expanded label. This indicates a significant step in the regulatory process for the pharmaceutical product.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH30m agoEuropean disease control center sends experts to Nigeria while Ebola cases surpass 10,000 in CongoEuroNews [en]HEALTH50m agoAfrica Ebola outbreak passes 10,000 cases, mostly in DR CongoVanguard NigeriaHEALTH1h agoAfrica Ebola outbreak passes 10,000 cases, mostly in DR CongoLe Monde [en]HEALTH1h agoAfrica Ebola Outbreak Passes 10,000 Cases, Mostly In DR CongoChannels TV